Key result
Blockade of the renin-angiotensin system by saralasin may provide a noninvasive means of identifying renovascular hypertension and managing hypertensive crises.
Why the study?
Does saralasin provide diagnostic and therapeutic utility in patients with renovascular hypertension or hypertensive crises?
Does saralasin provide diagnostic and therapeutic utility in patients with renovascular hypertension or hypertensive crises?
Answers are grounded in this paper and cite their sources.
Saralasin may serve as a useful diagnostic tool for identifying renovascular hypertension and a therapeutic agent for managing hypertensive crises driven by angiotensin excess.
Blockade of the renin-angiotensin system by the angiotensin analogue saralasin may have both diagnostic and therapeutic applications. Response to this investigational drug appears to provide a noninvasive means of identifying patients with renovascular and some other “angiotensinogenic” hypertensions. It is also seen as potentially useful in the management of hypertensive crises or states exacerbated by angiotensin excess.
No takes yet. Share an insight, caveat, or question.
Streeten et al. (1975) conducted a review in Hypertension. Saralasin was evaluated. Blockade of the renin-angiotensin system by saralasin may provide a noninvasive means of identifying renovascular hypertension and managing hypertensive crises.
Synapse has enriched 10 related papers. Consider them for comparative context: